News

Under a phase 1b/2 study, Kite’s investigational anti-CD19 Chimeric Antigen Receptor (CAR) T cell product, KTE-C19, will be evaluated with Genentech’s investigational anti-PDL1 antibody atezolizumab. The study, which

The primary endpoint of the study demonstrated that the Advair Diskus-combination (FSC) twice-daily showed non-inferiority compared to corresponding doses of fluticasone propionate (FP) twice-daily on the risk of

Kovaltry is an unmodified full-length recombinant factor VIII product, which is designed to reduce bleeding in patients with hemophilia A when administered prophylactically two or three times a

Researchers in Queensland, Australia, believe their work shows compounds in tarantula venom that may lead to more efficient painkillers. Individual peptide toxins called ProTx-II, from the Peruvian Green

University of Idaho researchers are closing in on synthesizing the healthy hop compounds. The compounds lupulones and humulones are of particular interest to the researchers, with the latter

408 people aged 18 and over were recruited through an online crowdsourcing marketplace and completed a survey regarding their viewing habits. The results were examined for potential TV

The agreement is notable in that it provides an exclusive access to Marina’s SMARTICLES and DiLA2 platforms for a different gene editing field than was announced on February

Major amendments to the protocol include the addition of talimogene laherparepvec (Imlygic) as an option for use as comparator. The amended protocol also extends eligibility to include Stage

NICE will now be able to make decisions on cancer drugs faster than ever before. For the first time NICE will issue draft guidance on new cancer drugs